Search results

Evidence-based recommendations on pegaspargase (Oncaspar) for treating acute lymphoblastic leukaemia.

Result type

Technology appraisal guidance

Published

28 September 2016

Evidence-based recommendations on ponatinib (Iclusig) for treating chronic myeloid leukaemia and acute lymphoblastic leukaemia in adults.

Result type

Technology appraisal guidance

Published

28 June 2017

Evidence-based recommendations on blinatumomab (Blincyto) with chemotherapy for consolidation treatment of Philadelphia-chromosome-negative CD19-positive minimal residual disease-negative B-cell precursor acute lymphoblastic leukaemia in adults.

Result type

Technology appraisal guidance

Published

26 March 2025